These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

805 related items for PubMed ID: 15468356

  • 1. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.
    Uribe AG, Vilá LM, McGwin G, Sanchez ML, Reveille JD, Alarcón GS.
    J Rheumatol; 2004 Oct; 31(10):1934-40. PubMed ID: 15468356
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.
    Ward MM, Marx AS, Barry NN.
    J Rheumatol; 2000 Mar; 27(3):664-70. PubMed ID: 10743805
    [Abstract] [Full Text] [Related]

  • 3. Validity of retrospective disease activity assessment in systemic lupus erythematosus.
    Arce-Salinas A, Cardiel MH, Guzmán J, Alcocer-Varela J.
    J Rheumatol; 1996 May; 23(5):846-9. PubMed ID: 8724296
    [Abstract] [Full Text] [Related]

  • 4. Systemic lupus erythematosus disease activity index 2000.
    Gladman DD, Ibañez D, Urowitz MB.
    J Rheumatol; 2002 Feb; 29(2):288-91. PubMed ID: 11838846
    [Abstract] [Full Text] [Related]

  • 5. Organ manifestations influence differently the responsiveness of 2 lupus disease activity measures, according to patients' or physicians' evaluations of recent lupus activity.
    Chang ER, Abrahamowicz M, Ferland D, Fortin PR.
    J Rheumatol; 2002 Nov; 29(11):2350-8. PubMed ID: 12415591
    [Abstract] [Full Text] [Related]

  • 6. Do lupus disease activity measures detect clinically important change?
    Fortin PR, Abrahamowicz M, Clarke AE, Neville C, Du Berger R, Fraenkel L, Liang MH.
    J Rheumatol; 2000 Jun; 27(6):1421-8. PubMed ID: 10852264
    [Abstract] [Full Text] [Related]

  • 7. Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices.
    Guzmán J, Cardiel MH, Arce-Salinas A, Sánchez-Guerrero J, Alarcón-Segovia D.
    J Rheumatol; 1992 Oct; 19(10):1551-8. PubMed ID: 1464867
    [Abstract] [Full Text] [Related]

  • 8. Can health utility measures be used in lupus research? A comparative validation and reliability study of 4 utility indices.
    Moore AD, Clarke AE, Danoff DS, Joseph L, Bélisle P, Neville C, Fortin PR.
    J Rheumatol; 1999 Jun; 26(6):1285-90. PubMed ID: 10381044
    [Abstract] [Full Text] [Related]

  • 9. Validity and reliability of lupus activity measures in the routine clinic setting.
    Petri M, Hellmann D, Hochberg M.
    J Rheumatol; 1992 Jan; 19(1):53-9. PubMed ID: 1556700
    [Abstract] [Full Text] [Related]

  • 10. The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity.
    American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria.
    Arthritis Rheum; 2004 Nov; 50(11):3418-26. PubMed ID: 15529383
    [Abstract] [Full Text] [Related]

  • 11. Summarizing disease features over time: II. Variability measures of SLEDAI-2K.
    Ibañez D, Gladman D, Urowitz M.
    J Rheumatol; 2007 Feb; 34(2):336-40. PubMed ID: 17183620
    [Abstract] [Full Text] [Related]

  • 12. Quantitative data for care of patients with systemic lupus erythematosus in usual clinical settings: a patient Multidimensional Health Assessment Questionnaire and physician estimate of noninflammatory symptoms.
    Askanase AD, Castrejón I, Pincus T.
    J Rheumatol; 2011 Jul; 38(7):1309-16. PubMed ID: 21459938
    [Abstract] [Full Text] [Related]

  • 13. Patterns of disease activity in systemic lupus erythematosus.
    Barr SG, Zonana-Nacach A, Magder LS, Petri M.
    Arthritis Rheum; 1999 Dec; 42(12):2682-8. PubMed ID: 10616018
    [Abstract] [Full Text] [Related]

  • 14. Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus.
    Brunner HI, Feldman BM, Bombardier C, Silverman ED.
    Arthritis Rheum; 1999 Jul; 42(7):1354-60. PubMed ID: 10403262
    [Abstract] [Full Text] [Related]

  • 15. Outcome measures to be used in clinical trials in systemic lupus erythematosus.
    Strand V, Gladman D, Isenberg D, Petri M, Smolen J, Tugwell P.
    J Rheumatol; 1999 Feb; 26(2):490-7. PubMed ID: 9972993
    [Abstract] [Full Text] [Related]

  • 16. Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation.
    Gladman DD, Goldsmith CH, Urowitz MB, Bacon P, Bombardier C, Isenberg D, Kalunian K, Liang MH, Maddison P, Nived O.
    J Rheumatol; 1994 Aug; 21(8):1468-71. PubMed ID: 7983648
    [Abstract] [Full Text] [Related]

  • 17. Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations.
    Vilá LM, Alarcón GS, McGwin G, Friedman AW, Baethge BA, Bastian HM, Fessler BJ, Reveille JD, LUMINA Study Group.
    Rheumatology (Oxford); 2004 Mar; 43(3):358-63. PubMed ID: 14623949
    [Abstract] [Full Text] [Related]

  • 18. Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity.
    Neville C, Clarke AE, Joseph L, Belisle P, Ferland D, Fortin PR.
    J Rheumatol; 2000 Mar; 27(3):675-9. PubMed ID: 10743807
    [Abstract] [Full Text] [Related]

  • 19. Testosterone patches in the management of patients with mild/moderate systemic lupus erythematosus.
    Gordon C, Wallace DJ, Shinada S, Kalunian KC, Forbess L, Braunstein GD, Weisman MH.
    Rheumatology (Oxford); 2008 Mar; 47(3):334-8. PubMed ID: 18238794
    [Abstract] [Full Text] [Related]

  • 20. The effect of menopause on disease activity in systemic lupus erythematosus.
    Urowitz MB, Ibañez D, Jerome D, Gladman DD.
    J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.